6533b82cfe1ef96bd128f30b
RESEARCH PRODUCT
Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento ( I ). Enfermedad del hígado graso no alcohólico y su asociación con la enfermedad cardiovascular
Juan F. AscasoÁNgel DíazPedro González-santosJesús MillánMariano BlascoTeresa MantillaAntonio Hernández MijaresJuan Pedro-botetÁNgel BreaXavier Pintósubject
medicine.medical_specialtyPathologyCirrhosisHigh prevalencebusiness.industryFatty livernutritional and metabolic diseasesArteriosclerosis030204 cardiovascular system & hematologymedicine.diseaseGastroenterologydigestive system diseases03 medical and health sciences0302 clinical medicineInternal medicinemedicine030211 gastroenterology & hepatologyPharmacology (medical)Liver damageSteatosisSteatohepatitisCardiology and Cardiovascular MedicineLiver cancerbusinessdescription
Non-alcoholic fatty liver disease (NAFLD) comprises a series of histologically lesions similar to those induced by alcohol consumption in people with very little or no liver damage. The importance of NAFLD is its high prevalence in the Western world and, from the point of view of the liver, in its gradual progression from steatosis to steatohepatitis, cirrhosis, and liver cancer. During the last decade it has been observed that NAFLD leads to an increased cardiovascular risk with acceleration of arteriosclerosis and events related to it, being the main cause of its morbidity and mortality. This review, updated to January 2016, consists of two parts, with the first part analysing the association of NAFLD with cardiovascular disease.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2017-05-01 | Clínica e Investigación en Arteriosclerosis |